Skip to main content
Article
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
Neuro-Oncology Advances
  • Yazmin Odia, Miami Cancer Institute
  • Doured Daghistani, Miami Cancer Institute
  • Zuanel Diaz, Miami Cancer Institute
  • Matthew Hall, Miami Cancer Institute
Publication Date
9-13-2022
Content Type
application/pdf
PubMed ID:
36382108
Additional Authors:

Additional authors and institutional affiliations

Citation Information

Gardner, S. L., Tarapore, R. S., Allen, J., McGovern, S. L., Zaky, W., Odia, Y., Daghistani, D., Diaz, Z., Hall, M. D., Khatib, Z., Koschmann, C., Cantor, E., Kurokawa, R., MacDonald, T. J., Aguilera, D., Vitanza, N. A., Mueller, S., Kline, C., Lu, G., Allen, J. E., … Khatua, S. (2022). Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neuro-oncology advances, 4(1), vdac143. https://doi.org/10.1093/noajnl/vdac143